Skip to Main Content

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. 

Telehealth is steering clear of the abortion pill


During the pandemic, the FDA eased limitations on telehealth prescriptions and mail delivery for certain drugs — including abortion pills, which can be used safely and effectively in the first 10 weeks of pregnancy. In December, the FDA made that access permanent — but so far, telehealth startups aren’t jumping to provide the pills. Companies including Hims & HersNurxTia, and PillPack, many of which frame their offerings around reduced stigma and increased sexual freedom, have chosen not to offer the treatment, with some employees citing fear that political controversy could harm their businesses’ growth. STAT’s Olivia Goldhill has the full story.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.